Profile
Niels Tækker Foged was the founder who founded Osteopro A in 1998, where he held the title of Chief Executive Officer.
He also held the position of Head-Research & Development at Dako Denmark ApS from 1991 to 2006.
Dr. Foged's former jobs include being an Independent Director at Bioporto A from 2007 to 2013, Director & Chief Scientific Officer at Visiopharm A in 2009, Director at In Situ RCP A, and Chief Scientific Officer at Euro-Diagnostica AB.
Dr. Foged's education includes an undergraduate degree from the Technical University of Denmark in 1985 and a doctorate degree from the University of Copenhagen in 1992.
Former positions of Niels Tækker Foged
| Companies | Position | End |
|---|---|---|
| BIOPORTO A/S | Director/Board Member | 2013-02-24 |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Chief Tech/Sci/R&D Officer | - |
| Osteopro A/S | Founder | - |
Euro-Diagnostica AB
 Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Chief Tech/Sci/R&D Officer | - |
In Situ RCP A/S
 In Situ RCP A/S Medical SpecialtiesHealth Technology Situ RCP A/S develops technology for anti-cancer treatments. The firm develops genetic diagnosing methods to identify malignant cancer cells compared to benign cells. The company was founded in July 2006 and is headquartered in Aalborg, Denmark. | Director/Board Member | - |
Training of Niels Tækker Foged
| Technical University of Denmark | Undergraduate Degree |
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOPORTO A/S | Health Technology |
| Private companies | 5 |
|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
Euro-Diagnostica AB
Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Health Technology |
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Visiopharm A/S provides quantitative digital pathology solutions for biopharmaceutical companies, contract research organizations, academic medical centers, research institutes and hospitals. Its offers solutions such as BIOTOPIX, ONCOTOPIX, and STEREOTOPIX. The company was founded by Michael Grunkin and Johan Doré Hansen in 2001 and is headquartered in Horsholm, Denmark. | Technology Services |
In Situ RCP A/S
In Situ RCP A/S Medical SpecialtiesHealth Technology Situ RCP A/S develops technology for anti-cancer treatments. The firm develops genetic diagnosing methods to identify malignant cancer cells compared to benign cells. The company was founded in July 2006 and is headquartered in Aalborg, Denmark. | Health Technology |
| Osteopro A/S |
- Stock Market
- Insiders
- Niels Tækker Foged